Related references
Note: Only part of the references are listed.Expression of the new CXCL12 receptor, CXCR7, in gliomas
Chiara Calatozzolo et al.
CANCER BIOLOGY & THERAPY (2011)
Atypical chemokine receptors
Maria Helena Ulvmar et al.
EXPERIMENTAL CELL RESEARCH (2011)
CXCL12/CXCR4 promotes motility and proliferation of glioma cells
Analia do Carmo et al.
CANCER BIOLOGY & THERAPY (2010)
The Chemokine Receptor CXCR7 Is Highly Expressed in Human Glioma Cells and Mediates Antiapoptotic Effects
Kirsten Hattermann et al.
CANCER RESEARCH (2010)
Concomitant CXCR4 and CXCR7 Expression Predicts Poor Prognosis in Renal Cancer
C. D'Alterio et al.
CURRENT CANCER DRUG TARGETS (2010)
The Peptidomimetic CXCR4 Antagonist TC14012 Recruits β-Arrestin to CXCR7 ROLES OF RECEPTOR DOMAINS
Stephanie Gravel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Monomeric Rhodopsin Is the Minimal Functional Unit Required for Arrestin Binding
Hisao Tsukamoto et al.
JOURNAL OF MOLECULAR BIOLOGY (2010)
Tracking G-protein-coupled receptor activation using genetically encoded infrared probes
Shixin Ye et al.
NATURE (2010)
β-arrestin- but not G protein-mediated signaling by the decoy receptor CXCR7
Sudarshan Rajagopal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling
Angelique Levoye et al.
BLOOD (2009)
Higher Expression of Chemokine Receptor CXCR7 Is Linked to Early and Metastatic Recurrence in Pathological Stage I Nonsmall Cell Lung Cancer
Shotaro Iwakiri et al.
CANCER (2009)
CXCL12, CXCR4 and CXCR7 Expression in brain metastases
Andrea Salmaggi et al.
CANCER BIOLOGY & THERAPY (2009)
CXCR4 mediates the proliferation of glioblastoma progenitor cells
Moneeb Ehtesham et al.
CANCER LETTERS (2009)
Imaging chemokine receptor dimerization with firefly luciferase complementation
Kathryn E. Luker et al.
FASEB JOURNAL (2009)
Elucidation of CXCR7-Mediated Signaling Events and Inhibition of CXCR4-Mediated Tumor Cell Transendothelial Migration by CXCR7 Ligands
Brian A. Zabel et al.
JOURNAL OF IMMUNOLOGY (2009)
AMD3100 Is a CXCR7 Ligand with Allosteric Agonist Properties
Irina Kalatskaya et al.
MOLECULAR PHARMACOLOGY (2009)
The Chemokine Receptors CXCR4 and CXCR3 in Cancer
Amy M. Fulton
CURRENT ONCOLOGY REPORTS (2009)
Chemokine receptors and other G protein-coupled receptors
David T. Lodowski et al.
CURRENT OPINION IN HIV AND AIDS (2009)
The biology of CCR5 and CXCR4
Ghalib Alkhatib
CURRENT OPINION IN HIV AND AIDS (2009)
Imaging Ligand-Dependent Activation of CXCR7
Kathryn E. Luker et al.
NEOPLASIA (2009)
Essential but differential role for CXCR4 and CXCR7 in the therapeutic homing of human renal progenitor cells
Benedetta Mazzinghi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Arrestin 3 mediates endocytosis of CCR7 following ligation of CCL19 but not CCL21
Melissa A. Byers et al.
JOURNAL OF IMMUNOLOGY (2008)
Rapid incorporation of functional rhodopsin into nanoscale apolipoprotein bound bilayer (NABB) particles
Sourabh Banerjee et al.
JOURNAL OF MOLECULAR BIOLOGY (2008)
CXCR7, CXCR4 and CXCL12: An eccentric trio?
Marcus Thelen et al.
JOURNAL OF NEUROIMMUNOLOGY (2008)
Cell surface targeting of μ-δ opioid receptor heterodirners by RTP4
Fabien M. Decaillot et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Structural Basis of CXCR4 Sulfotyrosine Recognition by the Chemokine SDF-1/CXCL12
Christopher T. Veldkamp et al.
SCIENCE SIGNALING (2008)
被撤回的出版物: The role of CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate cancer (Retracted article. See vol. 298, 2022)
Jianhua Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
LRRC4 inhibits glioblastoma cell proliferation, migration, and angiogenesis by downregulating pleiotropic cytokine expression and responses
Minghua Wu et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2008)
Allosteric transinhibition by specific antagonists in CCR2/CXCR4 heterodimers
Denis Sohy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature
Zhenhua Miao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
In situ expression of IFN-γ-inducible T cell α chemoattractant in breast cancer mounts an enhanced specific anti-tumor immunity which leads to tumor regression
Yiwei Chu et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7
Frederic Sierro et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
β-arrestin-biased ligands at seven-transmembrane receptors
Jonathan D. Violin et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2007)
Receptor heterodimerization leads to a switch in signaling:: β-arrestin2-mediated ERK activation by μ-δ opioid receptor heterodimers
Raphael Rozenfeld et al.
FASEB JOURNAL (2007)
Regulation of CXCR4 signaling
John M. Busillo et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2007)
A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development
Jennifer M. Burns et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Allosteric modulation of binding properties between units of chemokine receptor homo- and hetero-oligomers
JY Springael et al.
MOLECULAR PHARMACOLOGY (2006)
Distinct β-arrestin- and G protein-dependent pathways for parathyroid hormone receptor-stimulated ERK1/2 activation
D Gesty-Palmer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes
K Balabanian et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Novel cellular genes essential for transformation of endothelial cells by Kaposi's sarcoma-associated herpesvirus
C Raggo et al.
CANCER RESEARCH (2005)
Paired activation of two components within muscarinic M3 receptor dimers is required for recruitment of β-arrestin-1 to the plasma membrane
F Novi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Transduction of receptor signals by β-arrestins
RJ Leftowitz et al.
SCIENCE (2005)
Bioluminescence resonance energy transfer reveals ligand-induced conformational changes in CXCR4 homo- and heterodimers
Y Percherancier et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Evidence for negative binding cooperativity within CCR5-CCR2b heterodimers
L El-Asmar et al.
MOLECULAR PHARMACOLOGY (2005)
Heterodimerization of V1a and V2 vasopressin receptors determines the interaction with β-arrestin and their trafficking patterns
S Terrillon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Differential kinetic and spatial patterns of β-arrestin and G protein-mediated ERK activation by the angiotensin II receptor
SK Ahn et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Constitutive protease-activated receptor-2-mediated migration of MDA MB-231 breast cancer cells requires both β-arrestin-1 and -2
L Ge et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Roles of G-protein-coupled receptor dimerization - From ontogeny to signalling regulation
S Terrillon et al.
EMBO REPORTS (2004)
β-Arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors
M Azzi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Independent β-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2
HJ Wei et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
A β-arrestin-dependent scaffold is associated with prolonged MAPK activation in pseudopodia during protease-activated receptor-2-induced chemotaxis
L Ge et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
β-arrestin2 is critically involved in CXCR4-mediated chemotaxis, and this is mediated by its enhancement of p38 MAPK activation
Y Sun et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Defective lymphocyte chemotaxis in β-arresting2-and GRK6-deficient mice
AM Fong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Chemokine receptors: Multifaceted therapeutic targets
AEI Proudfoot
NATURE REVIEWS IMMUNOLOGY (2002)
Chemokine receptor homo- or heterodimerization activates distinct signaling pathways
M Mellado et al.
EMBO JOURNAL (2001)
Involvement of chemokine receptors in breast cancer metastasis
A Müller et al.
NATURE (2001)
β-arrestin differentially regulates the chemokine receptor CXCR4-mediated signaling and receptor internalization, and this implicates multiple interaction sites between β-arrestin and CXCR4
ZJ Cheng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
